Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
GSK, RSV and Shingles
GSK's RSV vaccine meets main goal when co-administered with shingles shot
British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles shot, met the main goal of a late-stage trial in adults over 50 years of age.
GSK Sees Positive Results in Trial of Combination RSV, Shingles Vaccine
GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older.
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The study showed a non-inferior immune response and good safety profiles. The results will support regulatory submissions to the FDA and EMA.
GSK's RSV, Shingles vaccines show on-par immune response in joint trial
(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same immune response in a late-stage trial as separate adminstration of the vaccines.
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses compared with separate administration of the vaccines.
GSK Builds Combo Case for RSV, Shingles Shots With Phase III Data
If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients and potentially bolster GSK’s faltering sales for both vaccines.
GSK pursues co-administration of RSV and shingles vaccines
GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new hope.
Good signs for co administration of GSK’s RSV and shingles vaccines
UK drugmaker GSK presented positive Phase III trial data at the European Geriatric Medicine Society Congress. The trial showed that co-administering Arexvy (RSV vaccine) and Shingrix (shingles vaccine) in adults 50+ produced a non-inferior immune response and was well tolerated.
GSK Reports Findings on Coadministered RSV and Shingles Vaccines
Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.
GSK Reports Positive Data From Co-administration Of RSV And Shingles Vaccines
GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the
Joplin Globe
3d
GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX
8 About AREXVY (Respiratory Syncytial Virus
Vaccine
, Adjuvanted) AREXVY contains recombinant
RSV
glycoprotein F stabilized in the prefusion conformation (RSVPreF3). This antigen is combined with ...
9d
on MSN
COVID-19, flu and RSV shots: Q&A with a pharmacist
Vaccinations have become a traditional part of flu season with the influenza vaccine revised most years to protect from new ...
The American Journal of Managed Care
4d
New RSV Vaccine Is Likely Cost-Effective for Older Adults, Study Finds
Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Secret Service admits failure
Actress Crosby dies at 90
Ga. suspect's mom indicted
Russia threatens retaliation
Feds subpoena Schaeffer
Pandas leaving for China
Drug price challenge revived
WI high court to decide
Rejects CNN debate invite
Released after guilty plea
SC 1st execution in 13 years
Boeing defense chief exits
1st rabies outbreak in seals
House repeals emission rules
Hiker injured in bear attack
FDA approves flu vaccine
Sesame Place suit verdict
144K+ Mavericks recalled
$230 million crypto theft
CAH sues for trespassing
TN abortion law blocked
Sues pharmacy middlemen
Biden hosts 'Quad' summit
Hand count approved in GA
Top Hezbollah leader killed?
J&J unit files for bankruptcy
CA bill to protect kids online
Bill to boost security OK'd
Beirut strike death toll
ISR strike on Gaza school
In-person voting begins
Feedback